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Accumulation of p53 protein in inverted
transitional cell papilloma of the urinary bladder
K W Chan, K Y Lam, G Srivastava
Abstract
Aims-To study the possible accumulation
ofp53 protein in inverted papilloma ofthe
urinary bladder.
Methods-Formalin fixed, paraffin wax
embedded sections from 14 cases of in-
verted papilloma of the urinary bladder
were studied retrospectively. Accumu-
lation of p53 was detected by immuno-
histochemistry using a mouse monoclonal
antibody directed against p53. p53 protein
reactivity was scored as follows: 0 = 10%;
1 = 10% to <30%; 2 = 30% to <50%; and 3=
>50% of cells p53 positive.
Results-The 14 sections were scored as
follows: 3 in four cases; 2 in four cases; 1
in one case; and 0 in five cases. Overall,
nine (64%) of the 14 cases were positive
for p53 protein.
Conclusions-The accumulation of p53
protein in inverted papilloma of the urin-
ary bladder suggests that p53 may have
has an important role in the neoplastic
process of this tumour. However, the be-
nign nature of inverted papillomas sug-
gests that p53 protein accumulation is not
related to tumour invasiveness and meta-
stasis. p53 reactivity cannot be used as a
marker of malignancy for urothelial neo-
plasia. Further studies are required to
determine the role of p53 protein in the
oncogenesis of urothelial neoplasms.
(J7 Clin Pathol: Mol Pathol 1996;49:M43-M45)
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Urothelial inverted papilloma is an uncommon
benign tumour that may be mistaken for pap-
illary transitional cell carcinoma. These two
tumours can be difficult to differentiate on
routine histological examination. While p53
gene mutations are common in transitional cell
carcinomas of urinary bladder,'" their fre-
quency in urothelial inverted papillomas is un-
known. The aim of this study was to ascertain
whether p53 protein is accumulated in inverted
papillomas and whether it can be used to dis-
tinguish inverted papillomas from papillary
transitional cell carcinoma.
The p53 gene encodes a 53 kDa nuclear
phosphoprotein which acts as a tumour sup-
pressor gene.5 The wild-type p53 protein is
associated with the control of the normal cell
cycle, DNA repair and synthesis, cell differ-
entiation, genomic plasticity, and apoptosis.
The gene is located on the short arm of chro-
mosome 17 and it consists of 11 exons, in-
cluding five conserved regions in which most
of the p53 mutations in tumours have been
found.6 The wild-type p53 protein is almost
undetectable because of its short half-life of
only five to 20 minutes. Mutant p53, however,
can be detected by immunohistochemistry.7 We
studied the accumulation of p53 protein in
archival formalin fixed, paraffin wax embedded
tissue using a standard immunohistochemical
method, incorporating the DO-7 antibody dir-
ected against p53 and heat mediated antigen
retrieval, because this method is reliable and
easy to use.8
Methods
Routinely processed paraffin wax blocks of 16
cases of urothelial inverted papilloma were re-
trieved from the files of the Department of
Pathology, Queen Mary Hospital, Hong Kong.
The original slides on which the diagnosis was
made were reviewed. The clinical history as
entered on the biopsy request forms was noted.
Two cases were excluded as there was in-
sufficient tissue in one and severe artefacts were
present in the other.
Sections (5 jtm) from the paraffin wax blocks
were de-paraffinised and rehydrated. They
were treated with 3% hydrogen peroxide for
10 minutes, washed in water and rinsed with
Tris buffered saline (TBS) at pH 7-6. Sections
were wholly immersed in 10mM citrate buffer
at pH 6-0 and irradiated in a microwave oven
(Energy Beam Sciences Inc., H2500 Micro-
wave Processor, Agawam, Massachusetts,
USA) at 95°C for nine minutes. Then, 10%
normal rabbit serum was added at room tem-
perature for 10 minutes. Primary mouse mono-
clonal antibody directed against p53, NCL-
p53-DO-7 diluted 1 in 25 (Novocastra Labora-
tories, Newcastle, UK), was added and the
sections were incubated in a moist chamber
overnight at 4°C. The antibody recognises both
wild-type and mutant p53. The sections were
then washed three times for three minutes each
in 0 05M TBS. Biotinylated rabbit anti-mouse
immunoglobulin (diluted 1 in 100, Dako-
E354, Dako, Copenhagen, Denmark) was
added and incubated at 37°C for 30 minutes.
The sections were again washed three times
for three minutes each in 0-05 M TBS. Strept-
avidin-biotin complexes/horseradish per-
oxidase (diluted 1 in 100; Dako-K377) was
added and the sections were incubated in a
moist chamber for 45 minutes at 37°C. The
sections were then washed three times for three
minutes each in 0-05 M TBS and were de-
veloped in freshly prepared diaminobenzidine/
H202 solution for six minutes at room tem-
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Demographic data of patients, tumour size and p53 score
for 14 inverted papillomas of the urinary bladder
Case Size Age p53
No. (mm) (years) Sex score
1 12 39 M 3
2 4 60 M 3
3 6 52 M 3
4 4 75 M 3
5 5 65 M 2
6 12 56 M 1
7 4 56 F 2
8 2 72 M 0
9 10 75 M 0
10 3 64 M 0
11 10 43 F 2
12 5 42 M 2
13 4 77 F 0
14 10 68 M 0
perature. The sections were washed in water,
counterstained with Mayer's haematoxylin for
one minute at room temperature, dehydrated,
cleared, and mounted. Sections of all 14 in-
verted papillomas where the primary antiserum
was omitted served as negative controls.
Staining of p53 was scored using a standard
light microscope (x 400). The percentage of
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p53 positive cases was determined by counting
500 cells and the cases were divided into four
categories as follows: 0 = < 10% of tumour cells
positive; 1 = 10% to <30% positive; 2=30%
to 50% positive; and 3= >50% positive.
Results
Fourteen inverted papillomas of the urinary
bladder were studied. Eleven were from men
and three from women (table). The mean age
of the patients was 60 3 years (range 39 to 77
years). Three of the inverted papillomas (cases
2, 9 and I 1) were initially reported as papillary
carcinoma, either grade I or II. All 14 patients
underwent complete transurethral resection of
the tumour. Recurrent disease has not been
documented in any of these 14 cases. Follow
up ranged from nine to 102 months (mean 46
months). One patient (case 7) was diagnosed
with carcinoma of cervix one year after her
tumour of the bladder was detected and under-
went total hysterectomy and post-operative
radiotherapy. She was also receiving chemo-
therapy for acute promyelocytic leukaemia.
p53 immunoreactivity was observed in the
nuclei, but not in the cytoplasm, of the tumour
cells (figure). Less than 10% of stromal cells
were p53 positive. The table lists the size of
the papillomas, age and sex of the patients and
p53 scores. Tumour size ranged from 2 to
12 mm. Staining of p53 protein was scored as
follows: 3 in four cases; 2 in four cases; 1 in
one case; and 0 in five cases. Overall, nine
(64%) of 14 cases were positive for p53 protein.
Discussion
Inverted papilloma of the urothelium may be
mistaken for papillary transitional cell car-
cinoma.9'2 Of the 14 inverted papillomas
studied here, three had been diagnosed as car-
4,.,cinoma. However, there was no evidence of
these tumours behaving in a clinically ag-
gressive manner and there were no metastasis
or recurrence after complete transurethral re-
section. This underscores the fact that, on
histological examination, differential diagnosis
of inverted papilloma and carcinoma is not
always easy. Other methods-for example, flow
cytometry to determine DNA ploidy, may help
in the differential diagnosis.'2
About halfofall cases ofcancer are associated
with mutant p53 protein. Some premalignant
lesions-for example, colorectal adenomas,
also show nuclear accumulation of p53 protein
in up to 42% of cases.'3 Benign lesions are
seldom investigated for their p53 status. Pig-
natelli et al'3 did not detect specific staining for
- p53 in the four normal large bowel mucosal
and the five colorectal metaplastic polyps they
examined. Other studies have shown that ac-
4 'l*^, * cumulation ofp53 protein is common in trans-
itional cell carcinoma, 4 and carcinoma in situ
and dysplasia'4 of the urinary bladder. The
reported incidence varies from 20 to 71% de-
aiiZ } pending on the tumour stage. To the best
4
_ .e: i+;ofour knowledge, the p53 status in benign
foma of the urinary bladder tumours of the urinary bladder has not been
reported previously. Our results show that ac-
S1.
p53 nuclear positivity in an inverted transitional cell papill
( x 300; case 1; p53 score= 3).
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p53 accumulation in inverted papillomas of the urinary bladder
cumulation of p53 protein is prevalent in in-
verted papillomas of the urinary bladder, with
an incidence comparable with that in bladder
carcinomas. This simple investigation, how-
ever, cannot be used to differentiate this benign
tumour from carcinoma. The results reported
here are in accordance with the supposition
that the p53 gene is mainly concerned in the
control of cellular proliferation5 and it has little
or no direct effect on tumour invasiveness and
metastasis. Other studies, however, have shown
that accumulation of p53 in bladder cancers is
highly associated with tumour grade and stage,
12 and with recurrence and death, and thus may
be useful in determining prognosis.'415
Gene mutation is not solely responsible for
accumulation of p53. Interaction with viral
proteins" and possibly cellular proteins" can
lead to stabilisation of the wild-type protein,
allowing it to be detected by immunohisto-
chemistry. Overexpression may also result from
inducer activity following genotoxic damage.'7
A prospective study on fresh tumour tissue
is warranted to identify the exact mechanism
responsible for the accumulation of p53 in
individual cases.
In conclusion, accumulation of the p53 pro-
tein was common in inverted papillomas of the
urinary bladder, but cannot be used as a marker
of malignancy.
This study is supported by a research grant (CRCG 335/046/
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